New ophthalmic drug delivery systems.

Area of Science:

• Ophthalmology
• Pharmaceutics
• Drug Delivery Systems

Background:

• Topical eye drops are the traditional method for ophthalmic drug administration.
• Newer formulations like suspensions, emulsions, and ointments enhance drug residence time.
• Advanced systems including devices and inserts offer sustained drug release.

Purpose of the Study:

• To review current developments in ophthalmic drug administration.
• To explore both topical and intravitreal drug delivery routes.
• To highlight emerging technologies and those under investigation.

Main Methods:

• Literature review of current and investigational ophthalmic drug delivery systems.
• Analysis of advancements in galenic formulations and novel administration devices.
• Examination of intravitreal administration techniques and available implants.

Main Results:

• Significant progress in developing formulations (suspensions, emulsions, ointments) to prolong ocular drug exposure.
• Emergence of sustained-release systems like inserts and nanostructures (nanocapsules, nanoemulsions).
• Availability of intravitreal implants in Europe for posterior segment diseases like AMD and diabetic macular edema.

Conclusions:

• Ophthalmic drug delivery is advancing with novel formulations and sustained-release technologies.
• Intravitreal administration offers targeted treatment for posterior eye segment conditions.
• Ongoing research into nanostructures and advanced devices promises further improvements in ophthalmic therapeutics.